Physician profile
Jordan Davidner
NPI 1609304484
$1,407.75
in general payments reported to CMS, 2019-2025
9 companies · $831 in 2025
The $831 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $215 · 2021: $274 · 2022: $11.89 · 2023: $17.83 · 2024: $57.52 · 2025: $831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $887 · Consulting Fee: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $886.69 |
| Consulting Fee | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $377.86 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $344.01 | 2025 | Infuse, Xiidra, Miebo |
| Tarsus Pharmaceuticals, INC. | $220.72 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $215.89 | 2022-2025 | Tryptyr, Precision7 |
| Glaukos Corporation | $111.31 | 2021 | |
| Rxsight INC | $63.41 | 2025 | Rxsight Injector Cartridge, Rxsight Injector Handpiece, Rxsight Contact Lens |
| Sun Pharmaceutical Industries INC. | $36.72 | 2025 | |
| Coopervision INC. | $20.00 | 2025 | Misight Contact Lens |
| Johnson & Johnson Vision Care, INC. | $17.83 | 2023 | Acuvue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Davidner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.